430 related articles for article (PubMed ID: 36973491)
1. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems.
Baryakova TH; Pogostin BH; Langer R; McHugh KJ
Nat Rev Drug Discov; 2023 May; 22(5):387-409. PubMed ID: 36973491
[TBL] [Abstract][Full Text] [Related]
2. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.
Ryan R; Santesso N; Lowe D; Hill S; Grimshaw J; Prictor M; Kaufman C; Cowie G; Taylor M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007768. PubMed ID: 24777444
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic dosing and drug delivery.
Rabin CR; Siegel SJ
Curr Top Behav Neurosci; 2010; 4():141-77. PubMed ID: 21312400
[TBL] [Abstract][Full Text] [Related]
4. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
[TBL] [Abstract][Full Text] [Related]
5. [Proceedings of new drug delivery systems and their applications in the traditional Chinese drugs].
Zhou SH; Xiao XH; Yuan HL; Zhao YL; Shan LM; Cai GM
Zhongguo Zhong Yao Za Zhi; 2003 Jul; 28(7):589-92. PubMed ID: 15139097
[TBL] [Abstract][Full Text] [Related]
6. Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies.
Yu L; Liu S; Jia S; Xu F
Biomed Pharmacother; 2023 Sep; 165():115049. PubMed ID: 37364480
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence and the use of new pharmaceutical formulations: the case of levothyroxine.
Scavone C; Sportiello L; Cimmaruta D; Sullo MG; Vitelli B; Rafaniello C; Fossati T; Rossi F
Minerva Endocrinol; 2016 Jun; 41(2):279-89. PubMed ID: 27015567
[TBL] [Abstract][Full Text] [Related]
8. Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings.
Wohlfahrt A; Campos A; Iversen MD; Gagne JJ; Massarotti E; Solomon DH; Feldman CH
PLoS One; 2018; 13(7):e0200886. PubMed ID: 30024938
[TBL] [Abstract][Full Text] [Related]
9. Delivery systems and dosing for antipsychotics.
Rabin CR; Siegel SJ
Handb Exp Pharmacol; 2012; (212):267-98. PubMed ID: 23129336
[TBL] [Abstract][Full Text] [Related]
10. Biomimetic drug-delivery systems for the management of brain diseases.
Chen YX; Wei CX; Lyu YQ; Chen HZ; Jiang G; Gao XL
Biomater Sci; 2020 Feb; 8(4):1073-1088. PubMed ID: 31728485
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design.
Stevenson J; Poker R; Schoss J; Campbell M; Everitt C; Holly B; Stones N; Pettis RJ; Sanchez-Felix M
Adv Drug Deliv Rev; 2024 Jun; 209():115322. PubMed ID: 38677443
[TBL] [Abstract][Full Text] [Related]
12. Applications of Novel and Nanostructured Drug Delivery Systems for the Treatment of Oral Cavity Diseases.
Hosseinpour-Moghadam R; Mehryab F; Torshabi M; Haeri A
Clin Ther; 2021 Dec; 43(12):e377-e402. PubMed ID: 34844769
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
14. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
15. Adherence With Oral Anticancer Therapies: Clinical Trial vs Real-world Experiences With a Focus on Prostate Cancer.
Higano CS; Hafron J
J Urol; 2023 Mar; 209(3):485-493. PubMed ID: 36472138
[TBL] [Abstract][Full Text] [Related]
16. Personalised Adherence Support for Maintenance Treatment of Inflammatory Bowel Disease: A Tailored Digital Intervention to Change Adherence-related Beliefs and Barriers.
Chapman S; Sibelli A; St-Clair Jones A; Forbes A; Chater A; Horne R
J Crohns Colitis; 2020 Oct; 14(10):1394-1404. PubMed ID: 32379303
[TBL] [Abstract][Full Text] [Related]
17. Novel drug delivery systems for glaucoma.
Lavik E; Kuehn MH; Kwon YH
Eye (Lond); 2011 May; 25(5):578-86. PubMed ID: 21475311
[TBL] [Abstract][Full Text] [Related]
18. Adherence monitoring in drug delivery.
Denyer J
Expert Opin Drug Deliv; 2010 Oct; 7(10):1127-31. PubMed ID: 20858164
[TBL] [Abstract][Full Text] [Related]
19. Carrageenan: A Wonder Polymer from Marine Algae for Potential Drug Delivery Applications.
Qureshi D; Nayak SK; Maji S; Kim D; Banerjee I; Pal K
Curr Pharm Des; 2019; 25(11):1172-1186. PubMed ID: 31465278
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
